{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1050282813890907648.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"HDL","@value":"http://hdl.handle.net/10091/17577"}},{"identifier":{"@type":"URI","@value":"https://soar-ir.repo.nii.ac.jp/records/3747"}},{"identifier":{"@type":"DOI","@value":"10.1111/j.1872-034x.2011.00937.x"}},{"identifier":{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1872-034X.2011.00937.x"}},{"identifier":{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1872-034X.2011.00937.x"}},{"identifier":{"@type":"PMID","@value":"22150950"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@language":"en","@value":"Risk of hepatitis B reactivation in patients treated with tumor necrosis factor-a inhibitors"},{"@value":"Risk of hepatitis B reactivation in patients treated with tumor necrosis factor‐α inhibitors"}],"dc:language":"en","description":[{"type":"Abstract","notation":[{"@value":"The use of tumor necrosis factor-a (TNF-a) inhibitors has been increasing especially in patients with rheumatoid arthritis (RA). As TNF-a inhibitors are strongly immunosuppressive, the occurrence of hepatitis B virus (HBV) reactivation has recently been observed. Reports suggest a higher risk of complicating HBV reactivation in carriers who are treated with TNF-a inhibitors. Therefore, HBV carriers are recommended to undergo prophylactic administration of nucleos(t)ide analogs (NAs). Our literary analysis uncovered several characteristics of de novo hepatitis B due to TNF-a inhibitors. First, the time between the start of TNF-a inhibitors and the occurrence of de novo hepatitis was longer than one year. Second, patients were usually treated with additional non-biologic agents, which also had immunosuppressive effects. Third, the disease could be fatal. Fourth, several types of TNF-a inhibitors exhibited a risk of developing de novo hepatitis. Although the incidence of de novo hepatitis B varied among reports (05%/year), it is suggested that patients with prior HBV infection are at risk of developing de novo hepatitis due to TNF-a inhibitors. Many reports maintain that regular measurement of HBV DNA is effective in preventing de novo hepatitis. Prophylactic administration of NAs is also considered useful to avoid de novo hepatitis, although the issue of cost-effectiveness needs to be addressed. Lastly, whereas maintenance of circulating anti-HBs titer using HB vaccines may be effective in responders to prevent de novo hepatitis, further studies are required to clarify the utility of HB vaccination."}]},{"type":"Other","notation":[{"@value":"Article"}]},{"type":"Other","notation":[{"@value":"HEPATOLOGY RESEARCH. 42(4):333-339 (2012)"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1420564276185767424","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"50163506"},{"@type":"NRID","@value":"1000050163506"},{"@type":"NRID","@value":"9000001538768"},{"@type":"NRID","@value":"9000248229860"},{"@type":"NRID","@value":"9000248229617"},{"@type":"NRID","@value":"9000412637659"},{"@type":"NRID","@value":"9000000311833"},{"@type":"NRID","@value":"9000001793433"},{"@type":"NRID","@value":"9000412637539"},{"@type":"NRID","@value":"9000412603949"},{"@type":"NRID","@value":"9000383839079"},{"@type":"NRID","@value":"9000015302830"},{"@type":"NRID","@value":"9000017670198"},{"@type":"NRID","@value":"9000412638543"},{"@type":"NRID","@value":"9000412603974"},{"@type":"NRID","@value":"9000022071886"},{"@type":"NRID","@value":"9000015182316"},{"@type":"NRID","@value":"9000020611003"},{"@type":"NRID","@value":"9000021394835"},{"@type":"NRID","@value":"9000323297090"},{"@type":"NRID","@value":"9000240057327"},{"@type":"NRID","@value":"9000266899158"},{"@type":"NRID","@value":"9000258246778"},{"@type":"NRID","@value":"9000283271789"},{"@type":"NRID","@value":"9000011297633"},{"@type":"NRID","@value":"9000414837637"},{"@type":"NRID","@value":"9000021933156"},{"@type":"NRID","@value":"9000347121112"},{"@type":"NRID","@value":"9000356560548"},{"@type":"NRID","@value":"9000399948185"},{"@type":"NRID","@value":"9000018653424"},{"@type":"NRID","@value":"9000248229364"},{"@type":"NRID","@value":"9000412603961"},{"@type":"NRID","@value":"9000412606054"},{"@type":"NRID","@value":"9000021483251"},{"@type":"NRID","@value":"9000392753034"},{"@type":"NRID","@value":"9000283271774"},{"@type":"NRID","@value":"9000414837736"},{"@type":"NRID","@value":"9000020168546"},{"@type":"NRID","@value":"9000021489796"},{"@type":"NRID","@value":"9000021483420"},{"@type":"NRID","@value":"9000386334677"},{"@type":"NRID","@value":"9000347121917"},{"@type":"NRID","@value":"9000345383107"},{"@type":"NRID","@value":"9000405891721"},{"@type":"NRID","@value":"9000258022322"},{"@type":"NRID","@value":"9000256340898"},{"@type":"NRID","@value":"9000412606063"},{"@type":"NRID","@value":"9000412626811"},{"@type":"NRID","@value":"9000383088595"},{"@type":"NRID","@value":"9000347119638"},{"@type":"NRID","@value":"9000283271762"},{"@type":"NRID","@value":"9000256338045"},{"@type":"NRID","@value":"9000270891257"},{"@type":"NRID","@value":"9000402898310"},{"@type":"NRID","@value":"9000263063149"},{"@type":"NRID","@value":"9000412637876"},{"@type":"NRID","@value":"9000021486037"},{"@type":"NRID","@value":"9000021429297"},{"@type":"NRID","@value":"9000021509348"},{"@type":"NRID","@value":"9000000503538"},{"@type":"NRID","@value":"9000018383486"},{"@type":"NRID","@value":"9000248228889"},{"@type":"NRID","@value":"9000412636851"},{"@type":"NRID","@value":"9000412637591"},{"@type":"NRID","@value":"9000412637842"},{"@type":"NRID","@value":"9000414837645"},{"@type":"NRID","@value":"9000412603953"},{"@type":"NRID","@value":"9000021211409"},{"@type":"NRID","@value":"9000312725838"},{"@type":"NRID","@value":"9000347119865"},{"@type":"NRID","@value":"9000258011333"},{"@type":"NRID","@value":"9000283422403"},{"@type":"NRID","@value":"9000256349524"},{"@type":"NRID","@value":"9000243872170"},{"@type":"NRID","@value":"9000412637853"},{"@type":"NRID","@value":"9000397942957"},{"@type":"NRID","@value":"9000412626712"},{"@type":"NRID","@value":"9000411808418"},{"@type":"NRID","@value":"9000404851669"},{"@type":"NRID","@value":"9000308383931"},{"@type":"NRID","@value":"9000412602640"},{"@type":"NRID","@value":"9000412637434"},{"@type":"NRID","@value":"9000021429364"},{"@type":"NRID","@value":"9000258246294"},{"@type":"NRID","@value":"9000412606070"},{"@type":"NRID","@value":"9000021430499"},{"@type":"NRID","@value":"9000021413017"},{"@type":"NRID","@value":"9000243721169"},{"@type":"NRID","@value":"9000020567382"},{"@type":"NRID","@value":"9000021930945"},{"@type":"NRID","@value":"9000021375293"},{"@type":"NRID","@value":"9000347120771"},{"@type":"NRID","@value":"9000256638683"},{"@type":"NRID","@value":"9000399801099"},{"@type":"NRID","@value":"9000381457040"},{"@type":"NRID","@value":"9000001023794"},{"@type":"NRID","@value":"9000022129001"},{"@type":"NRID","@value":"9000253017619"},{"@type":"NRID","@value":"9000254447257"},{"@type":"NRID","@value":"9000402071869"},{"@type":"NRID","@value":"9000010059669"},{"@type":"NRID","@value":"9000018388392"},{"@type":"NRID","@value":"9000010690991"},{"@type":"NRID","@value":"9000241893416"},{"@type":"NRID","@value":"9000311781379"},{"@type":"NRID","@value":"9000367827853"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read0010373"}],"foaf:name":[{"@language":"en","@value":"Tanaka,  Eiji"}]},{"@id":"https://cir.nii.ac.jp/crid/1070282813890907649","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Urata,  Yukitomo"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"13866346"},{"@type":"EISSN","@value":"1872034X"},{"@type":"NCID","@value":"AA11140867"}],"prism:publicationName":[{"@value":"HEPATOLOGY RESEARCH"}],"dc:publisher":[{"@value":"WILEY-BLACKWELL"}],"prism:publicationDate":"2012-04","prism:volume":"42","prism:number":"4","prism:startingPage":"333","prism:endingPage":"339"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","dc:rights":["Copyright© 2011 The Japan Society of Hepatology"],"url":[{"@id":"https://soar-ir.repo.nii.ac.jp/records/3747"},{"@id":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1872-034X.2011.00937.x"},{"@id":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1872-034X.2011.00937.x"}],"foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=hepatitis%20B","dc:title":"hepatitis B"},{"@id":"https://cir.nii.ac.jp/all?q=nucleos(t)ide%20analog","dc:title":"nucleos(t)ide analog"},{"@id":"https://cir.nii.ac.jp/all?q=de%20novo%20hepatitis%20B","dc:title":"de novo hepatitis B"},{"@id":"https://cir.nii.ac.jp/all?q=reactivation","dc:title":"reactivation"},{"@id":"https://cir.nii.ac.jp/all?q=rheumatoid%20arthritis","dc:title":"rheumatoid arthritis"},{"@id":"https://cir.nii.ac.jp/all?q=tumor%20necrosis%20factor-a%20inhibitor","dc:title":"tumor necrosis factor-a inhibitor"}],"dcterms:subject":[{"subjectScheme":"Other","notation":[{"@value":"hepatitis B"}]},{"subjectScheme":"Other","notation":[{"@value":"nucleos(t)ide analog"}]},{"subjectScheme":"Other","notation":[{"@value":"de novo hepatitis B"}]},{"subjectScheme":"Other","notation":[{"@value":"reactivation"}]},{"subjectScheme":"Other","notation":[{"@value":"rheumatoid arthritis"}]},{"subjectScheme":"Other","notation":[{"@value":"tumor necrosis factor-a inhibitor"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360565168116348928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JSH Guidelines for the Management of Hepatitis B Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848664146523648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206343157248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Newly Diagnosed CML-CP HBV Carrier was Safely Treated with Dasatinib and Entecavir"},{"@language":"ja","@value":"Entecavirとdasatinibを併用し，安全に治療継続し得たHBVキャリアの新規発症慢性骨髄性白血病慢性期"},{"@language":"ja-Kana","@value":"Entecavir ト dasatinib オ ヘイヨウ シ,アンゼン ニ チリョウ ケイゾク シエタ HBV キャリア ノ シンキ ハッショウ マンセイ コツズイセイ ハッケツビョウ マンセイキ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679771619840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two cases of acute hepatitis due to hepatitis E virus that are indigenous to Kitakyushu: a case report"},{"@language":"ja","@value":"北九州に土着したE型肝炎ウイルス株による急性肝炎の2例"},{"@value":"B型肝炎治療ガイドライン(第1.1版)"},{"@language":"ja-Kana","@value":"Bガタ カンエン チリョウ ガイドライン(ダイ1.1ハン)"},{"@language":"ja-Kana","@value":"キタキュウシュウ ニ ドチャク シタ Eガタ カンエンウイルスカブ ニ ヨル キュウセイ カンエン ノ 2レイ"},{"@value":"Guidelines for the management of hepatitis B virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1390582241583787520","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"De novo hepatitis B in a patient with negative hepatitis B core antibody and high normal range hepatitis B surface antibody treated with R-CHOP therapy for Diffuse large B-cell lymphoma"},{"@language":"ja","@value":"HBs抗体基準値内のためHBV再活性化非モニタリング下にde novo B型肝炎を発症した1例"},{"@language":"ja-Kana","@value":"HBs コウタイ キジュンチ ナイ ノ タメ HBV サイカッセイカ ヒモニタリング カ ニ de novo Bガタ カンエン オ ハッショウ シタ 1レイ"}]}],"dataSourceIdentifier":[{"@type":"IRDB","@value":"oai:irdb.nii.ac.jp:00990:0001368136"},{"@type":"CROSSREF","@value":"10.1111/j.1872-034x.2011.00937.x"},{"@type":"OPENAIRE","@value":"doi_dedup___::36470cc69f67e039626dc404266e5353"},{"@type":"CROSSREF","@value":"10.1111/hepr.12269_references_DOI_8smvtoyblPHn0F055schrxBrpQA"},{"@type":"CROSSREF","@value":"10.2974/kmj.64.51_references_DOI_8smvtoyblPHn0F055schrxBrpQA"},{"@type":"CROSSREF","@value":"10.3109/14397595.2013.852834_references_DOI_8smvtoyblPHn0F055schrxBrpQA"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.402_references_DOI_8smvtoyblPHn0F055schrxBrpQA"},{"@type":"CROSSREF","@value":"10.2957/kanzo.65.336_references_DOI_8smvtoyblPHn0F055schrxBrpQA"}]}